SCHEMBL30963858

SCHEMBL30963858

CC(C)Oc1cc(CN2CCNCC2)cc(-c2cncc(O)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.42
▸ TGFBR1 P36897 2/20 0.38
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ PDE2A O00408 1/20 0.36
▸ WNT1 P04628 4/20 0.36
▸ DYRK1A Q13627 4/20 0.36
▸ ACVR1 Q04771 1/20 0.35
▸ CHRNB2 P17787 2/20 0.35
▸ CHRNA4 P43681 2/20 0.35
▸ CLK2 P49760 1/20 0.35
▸ CLK3 P49761 1/20 0.35
▸ SSTR5 P35346 1/20 0.35
▸ CHRM3 P20309 4/20 0.34
▸ RIPK2 O43353 1/20 0.33
▸ NOD2 Q9HC29 1/20 0.33
▸ INPPL1 O15357 1/20 0.33
▸ CHRNB4 P30926 1/20 0.33
▸ CHRNA3 P32297 1/20 0.33
▸ CHRNA7 P36544 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30963864 0.86 CHRM3 (0.45) ALDH1A1TGFBR1CYP11B1CYP11B2CHRNB2
SCHEMBL30963887 0.83 CHRM3 (0.49) ALDH1A1CHRM3
SCHEMBL26680378 0.79 CCR5 (0.48) ALDH1A1
SCHEMBL26681027 0.77 RET (0.39) ALDH1A1PDE2AWNT1DYRK1A
SCHEMBL30963835 0.76 CYP3A4 (0.48) WNT1CHRNB2CHRNA4CHRM3
SCHEMBL26682906 0.76 OPRD1 (0.41) ALDH1A1
SCHEMBL26680397 0.74 MEN1 (0.43) ALDH1A1WNT1DYRK1ACLK2CLK3
SCHEMBL26682606 0.74 TP53 (0.43) —
SCHEMBL26682745 0.74 CHEK1 (0.46) ALDH1A1
SCHEMBL30687836 0.74 PPARA (0.36) ALDH1A1PDE2AWNT1DYRK1ACLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP MGMT, MCL1, FANCF ALDH1A1 446/4885TGFBR1 4846/4885CYP11B1 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback